Cellectar Biosciences, Inc. Notes Payable, Current
Cellectar Biosciences, Inc. (CLRB) had Notes Payable, Current of $0 as of 2017-12-31, per its 10-K filed 2018-03-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:NotesPayableCurrent · last filed 2018-03-21
- 2017-12-31: Notes Payable, Current $0.00.
- 2017-09-30: Notes Payable, Current $0.00.
- 2017-06-30: Notes Payable, Current $0.00.
- 2017-03-31: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-21 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 |
| 2016-12-31 | $86.59K 10-K · filed 2018-03-21 |
| 2016-09-30 | $147.94K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $208.89K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $244.81K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $243.59K 10-K · filed 2017-03-15 |
| 2015-09-30 | $242.38K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $240.75K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $180.37K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $119.92K 10-K/A · filed 2016-10-20 |
| 2014-09-30 | $103.33K 10-Q · filed 2015-05-20 |
| 2014-06-30 | $41.33K 10-Q · filed 2014-08-04 |
| 2013-12-31 | $0.00 10-Q · filed 2015-05-20 |
| 2010-12-31 | $204.80K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |